Phospholipid derived mediators and glomerulonephritis
The contributions made by the various eicosanoids, PAF, the HETES and the lipoxins to the pathophysiology of glomerulonephritis is reviewed. A case can be made for clinical trials of PAF, leukotriene and thromboxane antagonists. Combined thromboxane synthetase and thromboxane receptor antagonism wou...
Saved in:
Main Author: | E. N. Wardle (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1993-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery
by: Simon Drescher, et al.
Published: (2020) -
Phospholipids and sports performance
by: Purpura Martin, et al.
Published: (2007) -
Clinico-morphological comparison of the mesangiocapillary glomerulonephritis type I and diffuse lupus glomerulonephritis
by: О. V. Khmara, et al.
Published: (2013) -
Educational Case: Lupus Nephritis as an Example of Immune Complex-Mediated Glomerulonephritis
by: Deborah Jebakumar MD, et al.
Published: (2020) -
Mesangioproliferative glomerulonephritis: An important glomerulonephritis in nephrotic syndrome of young adult
by: Usha, et al.
Published: (2008)